AG
ACHC icon

Aperio Group’s Acadia Healthcare ACHC Stock Holding History

Aperio Group’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.27M Sell
25,315
-3,644
-13% -$145K ﹤0.01% 1453
2020
Q3 		$854K Buy
28,959
+90
+0.3% +$2.61K ﹤0.01% 1518
2020
Q2 		$725K Sell
28,869
-3,918
-12% -$97.8K ﹤0.01% 1571
2020
Q1 		$602K Buy
32,787
+12,422
+61% +$356K ﹤0.01% 1555
2019
Q4 		$677K Sell
20,365
-4,121
-17% -$129K ﹤0.01% 1646
2019
Q3 		$761K Sell
24,486
-20,870
-46% -$636K ﹤0.01% 1541
2019
Q2 		$1.59M Buy
45,356
+10,568
+30% +$342K 0.01% 1176
2019
Q1 		$1.02M Buy
34,788
+12,724
+58% +$360K ﹤0.01% 1366
2018
Q4 		$568K Buy
22,064
+2
+0% +$69 ﹤0.01% 1603
2018
Q3 		$777K Sell
22,062
-1,822
-8% -$72.6K ﹤0.01% 1545
2018
Q2 		$977K Sell
23,884
-521
-2% -$21K ﹤0.01% 1401
2018
Q1 		$956K Buy
24,405
+2,547
+12% +$93.4K ﹤0.01% 1349
2017
Q4 		$713K Sell
21,858
-8,329
-28% -$289K ﹤0.01% 1515
2017
Q3 		$1.44M Buy
30,187
+1,370
+5% +$66.8K 0.01% 1081
2017
Q2 		$1.42M Buy
28,817
+4,891
+20% +$217K 0.01% 1064
2017
Q1 		$1.04M Buy
23,926
+15,049
+170% +$611K 0.01% 1153
2016
Q4 		$294K Buy
8,877
+2,980
+51% +$116K ﹤0.01% 1801
2016
Q3 		$293K Sell
5,897
-742
-11% -$38.6K ﹤0.01% 1729
2016
Q2 		$368K Buy
6,639
+607
+10% +$35.5K ﹤0.01% 1561
2016
Q1 		$332K Buy
6,032
+1,699
+39% +$97K ﹤0.01% 1594
2015
Q4 		$271K Sell
4,333
-992
-19% -$64.6K ﹤0.01% 1675
2015
Q3 		$353K Buy
5,325
+1,171
+28% +$90.1K ﹤0.01% 1484
2015
Q2 		$325K Buy
4,154
+238
+6% +$17.1K ﹤0.01% 1580
2015
Q1 		$280K Sell
3,916
-335
-8% -$21.5K ﹤0.01% 1616
2014
Q4 		$260K Buy
+4,251
New +$247K ﹤0.01% 1598

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's ACHC Position: Q4 2020 in Review

Aperio Group reduced its Acadia Healthcare (ACHC) stake by 13% in Q4 2020, selling an estimated $145K and leaving 25,315 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

Aperio Group first reported a position in ACHC in Q4 2014 and has held it in 25 quarters since. The position peaked at $1.59M in Q2 2019. 264 funds tracked by Wall St. Rank hold ACHC as of Q4 2020.

  • Aperio Group held 25,315 shares of Acadia Healthcare worth $1.27M as of Q4 2020.
  • Aperio Group sold 3,644 Acadia Healthcare shares in Q4 2020, an estimated $145K.
  • Acadia Healthcare made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1453 holding.
  • Aperio Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 25 quarters since.
  • Aperio Group's Acadia Healthcare position peaked at $1.59M in Q2 2019.
  • 264 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.